Andreas M. Kany

Saarbruecken, SL 66123, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel Antibiotic.

Hit-to-Lead Optimization of Energy-Coupling Factor (ECF) Transporter Inhibitors as Novel Antibiotic.

Journal: Journal of medicinal chemistry
Published: June 06, 2026

Cytochrome P450-Mediated Metabolism of Antimycobacterial Nα-Aroyl-N-aryl-phenylalanine Amides.

Cytochrome P450-Mediated Metabolism of Antimycobacterial Nα-Aroyl-N-aryl-phenylalanine Amides.

Journal: ACS infectious diseases
Published: June 02, 2026

A new bactericidal thiourea antibiotic against drug-resistant Staphylococcus aureus with in vivo activity and no detectable resistance.

A new bactericidal thiourea antibiotic against drug-resistant Staphylococcus aureus with in vivo activity and no detectable resistance.

Journal: European journal of medicinal chemistry
Published: April 23, 2026

Structure Elucidation, Biosynthesis and Biological Evaluation of Neosorangicin A, a Member of the Sorangicin Family.

Structure Elucidation, Biosynthesis and Biological Evaluation of Neosorangicin A, a Member of the Sorangicin Family.

Journal: Journal of natural products
Published: March 19, 2026

Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic Administration.

Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic Administration.

Journal: Journal of medicinal chemistry
Published: February 05, 2026

Design, Synthesis, and Biological Evaluation of Mono- and Diamino-Substituted Squaramide Derivatives as Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthase.

Design, Synthesis, and Biological Evaluation of Mono- and Diamino-Substituted Squaramide Derivatives as Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthase.

Journal: Journal of medicinal chemistry
Published: November 24, 2025

Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2).

Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2/IMP2).

Journal: European journal of medicinal chemistry
Published: November 14, 2025

Tracheal tuft cell-released leukotrienes promote antibacterial immune responses.

Tracheal tuft cell-released leukotrienes promote antibacterial immune responses.

Journal: Cell reports
Published: November 13, 2025

Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen.

Toward Anti-Herpesviral PROTACs: Assessing the Challenges for Targeted Protein Degradation on the Example of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen.

Journal: ChemMedChem
Published: September 05, 2025

Microbial Cross-Talk: Unlocking the Cytochalasin Diversity from a Termite-Associated Xylaria.

Microbial Cross-Talk: Unlocking the Cytochalasin Diversity from a Termite-Associated Xylaria.

Journal: JACS Au
Published: August 26, 2025

Engineering an Artificial Myxopyronin Derivative with Enhanced Metabolic Stability via Mutasynthesis.

Engineering an Artificial Myxopyronin Derivative with Enhanced Metabolic Stability via Mutasynthesis.

Journal: JACS Au
Published: July 29, 2025

Tailored phenyl ureas eradicate drug-resistant Mycobacterium tuberculosis by targeting mycolic acid cell wall assembly.

Tailored phenyl ureas eradicate drug-resistant Mycobacterium tuberculosis by targeting mycolic acid cell wall assembly.

Journal: Chemical science
Published: April 06, 2025
Showing 1-12 of 46

Last Updated: 09/26/2026